BAUCE, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.809
AS - Asia 5.910
EU - Europa 4.836
SA - Sud America 1.713
AF - Africa 1.539
OC - Oceania 155
Continente sconosciuto - Info sul continente non disponibili 64
Totale 27.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.071
SG - Singapore 2.139
IT - Italia 1.558
BR - Brasile 1.152
CN - Cina 1.042
HK - Hong Kong 747
SE - Svezia 423
VN - Vietnam 392
DE - Germania 376
FI - Finlandia 324
NL - Olanda 198
PL - Polonia 162
FR - Francia 161
GB - Regno Unito 153
UA - Ucraina 152
RU - Federazione Russa 128
IN - India 118
AR - Argentina 102
TR - Turchia 85
EC - Ecuador 82
AT - Austria 79
BJ - Benin 75
KR - Corea 72
IQ - Iraq 71
MX - Messico 68
PY - Paraguay 67
GR - Grecia 66
ID - Indonesia 66
CI - Costa d'Avorio 65
IE - Irlanda 63
ZA - Sudafrica 63
JP - Giappone 58
ES - Italia 57
CH - Svizzera 55
CO - Colombia 53
CR - Costa Rica 51
IR - Iran 51
NI - Nicaragua 51
SA - Arabia Saudita 50
MK - Macedonia 49
MA - Marocco 48
VE - Venezuela 48
AE - Emirati Arabi Uniti 47
AM - Armenia 47
KE - Kenya 47
LV - Lettonia 47
CZ - Repubblica Ceca 46
DZ - Algeria 46
AL - Albania 45
AO - Angola 45
SI - Slovenia 45
UY - Uruguay 45
CA - Canada 44
JM - Giamaica 44
LY - Libia 44
ML - Mali 44
PE - Perù 44
EG - Egitto 43
GH - Ghana 43
IL - Israele 43
RS - Serbia 43
LA - Repubblica Popolare Democratica del Laos 42
LB - Libano 42
MG - Madagascar 42
PH - Filippine 42
SN - Senegal 42
YE - Yemen 42
CL - Cile 41
GF - Guiana Francese 41
RO - Romania 41
SK - Slovacchia (Repubblica Slovacca) 41
UZ - Uzbekistan 41
AZ - Azerbaigian 40
DK - Danimarca 40
HR - Croazia 40
MD - Moldavia 40
MW - Malawi 40
NP - Nepal 40
PK - Pakistan 40
BE - Belgio 39
MZ - Mozambico 39
TW - Taiwan 39
BA - Bosnia-Erzegovina 38
BY - Bielorussia 38
CY - Cipro 38
DO - Repubblica Dominicana 38
GT - Guatemala 38
IS - Islanda 38
LU - Lussemburgo 38
AU - Australia 37
BO - Bolivia 37
BZ - Belize 37
GE - Georgia 37
KZ - Kazakistan 37
ZW - Zimbabwe 37
BB - Barbados 36
CV - Capo Verde 36
KG - Kirghizistan 36
KH - Cambogia 36
PA - Panama 36
Totale 25.265
Salva come PNG Salva come JPEG
Città #
Fairfield 1.640
Ashburn 1.236
Singapore 1.046
Woodbridge 1.042
Houston 932
Chandler 778
Hong Kong 720
Ann Arbor 672
Seattle 588
Cambridge 558
Wilmington 536
Jacksonville 421
Beijing 327
Santa Clara 267
Boardman 239
Princeton 202
Padova 170
Los Angeles 155
San Diego 151
Milan 150
Munich 136
Ho Chi Minh City 126
Helsinki 123
Chicago 122
Roxbury 115
Bytom 107
Medford 100
São Paulo 94
Des Moines 87
Nanjing 87
Hanoi 77
Rome 77
Cotonou 73
New York 73
Hefei 64
Guangzhou 63
Abidjan 62
Turku 62
Salt Lake City 57
Buffalo 54
Vienna 49
Dong Ket 47
Managua 46
Dublin 45
Riga 44
San José 44
Dakar 41
Bamako 40
Luanda 40
Montevideo 40
Nairobi 40
Seoul 40
Baku 39
Dallas 39
Rio de Janeiro 39
Tashkent 39
Antananarivo 38
Turin 38
Bologna 36
Accra 35
Amman 35
Bridgetown 35
Conakry 35
Vientiane 35
Harare 34
Kampala 34
Nuremberg 34
Panama City 34
Phnom Penh 34
Kigali 33
Yerevan 33
Lusaka 32
Tokyo 32
Ulan Bator 32
Baghdad 31
Bishkek 31
Johannesburg 31
Libreville 31
Noumea 31
Tripoli 31
Villafranca Padovana 31
Lima 30
Maputo 30
Redondo Beach 30
Sanaa 30
Belo Horizonte 29
Brooklyn 29
Castries 29
Dushanbe 29
Lilongwe 29
London 29
Praia 29
Asunción 28
Djibouti 28
Durham 28
Kingstown 28
Kinshasa 28
Niamey 28
Nouakchott 28
Padua 28
Totale 15.644
Salva come PNG Salva come JPEG
Nome #
'Hot phase' clinical presentation in arrhythmogenic cardiomyopathy 436
The 2020 “Padua Criteria” for Diagnosis and Phenotype Characterization of Arrhythmogenic Cardiomyopathy in Clinical Practice 326
A targeted next-generation gene panel reveals a novel heterozygous nonsense variant in the TP63 gene in patients with arrhythmogenic cardiomyopathy 299
Cardiomiopatia/displasia aritmogena del ventricolo destro 291
Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy 286
Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse 274
Large Genomic Rearrangements of Desmosomal Genes in Italian Arrhythmogenic Cardiomyopathy Patients 248
Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy 240
Arrhythmogenic Cardiomyopathy 229
Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. 228
Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro. 223
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy 217
Arrhythmogenic cardiomyopathy 213
Predictive value of exercise testing in athletes with ventricular ectopy evaluated by cardiac magnetic resonance 213
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report 211
Homozygous desmocollin-2 mutations and arrhythmogenic cardiomyopathy 209
Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes. 207
Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement 206
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy 206
Follow-Up with Exercise Test of Effort-Induced Ventricular Arrhythmias Linked to Ryanodine Receptor Type 2 Gene Mutations. 203
Relationship between electrocardiographic findings and cardiac magnetic resonance phenotypes in arrhythmogenic cardiomyopathy 197
Electrocardiographic Pattern in Arrhythmogenic Right Ventricular Cardiomyopathy 196
The p.A897KfsX4 frameshift variation in desmocollin-2 is not a causative mutation in arrhythmogenic right ventricular cardiomyopathy 196
Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death 195
Mutations in the area composita protein alphaT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy 192
Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry 191
Imaging Study of Ventricular Scar in Arrhythmogenic Right Ventricular Cardiomyopathy: Comparison of 3D Standard Electroanatomical Voltage Mapping and Contrast-Enhanced Cardiac Magnetic Resonance. 190
Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy 188
Clinical phenotype and diagnosis of arrhythmogenic right ventricular cardiomyopathy in pediatric patients carrying desmosomal gene mutations. 186
PHENOTYPIC EXPRESSION IS A PREREQUISITE FOR MALIGNANT ARRHYTHMIC EVENTS AND SUDDEN CARDIAC DEATH IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY 186
Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. 186
Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia. 184
Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy. 184
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy 182
Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy 179
Determinants of Ventricular Arrhythmias in Mitral Valve Prolapse 177
Signal-averaged electrocardiogram in patients with arrhythmogenic right ventricular cardiomyopathy and ventricular arrhythmias 177
Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. 177
A microRNA expression profile as non-invasive biomarker in a large arrhythmogenic cardiomyopathy cohort 177
Imaging study of ventricular scar in arrhythmogenic right ventricular cardiomyopathy/dysplasia: comparison of three-dimensional electroanatomic voltage mapping and contrast-enhanced cardiac magnetic resonance 176
Three-Dimensional Electroanatomical Voltage Mapping and Histologic Evaluation of Myocardial Substrate in Right Ventricular Outflow Tract Tachycardia 176
Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete's heart adaptations 175
Arrhythmogenic cardiomyopathy: natural history and risk stratification 175
Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes 172
Cardiac magnetic resonance imaging of arrhythmogenic cardiomyopathy: evolving diagnostic perspectives 171
Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. 171
Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia 170
The "Padua classification" of cardiomyopathies: Combining pathobiological basis and morpho-functional remodeling 168
Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates. 165
Exercise-Induced Normalization of Right Precordial Negative T Waves in Arrhythmogenic Right Ventricular Cardiomyopathy. 165
Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy 164
Gender differences and role of pregnancy in the history of post-surgical women affected by tetralogy of Fallot. 161
Response to letters regarding article, "arrhythmic mitral valve prolapse and sudden cardiac death" 160
Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis 160
Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. 158
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria 158
A Comprehensive Analysis of Non-Desmosomal Rare Genetic Variants in Arrhythmogenic Cardiomyopathy: Integrating in Padua Cohort Literature-Derived Data 157
Response to Letters Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death" 157
529Relationship between ventricular mechanics and fibro-fatty replacement on cardiac magnetic resonance in arrhythmogenic cardiomyopathy 157
Desmin mutations and arrhythmogenic right ventricular cardiomyopathy. 156
Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) 156
Comparison of clinical features of arrhythmogenic right ventricular cardiomyopathy in men versus women 155
Causes of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in children 153
Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria 153
Denaturing HPLC-based approach for detecting RYR2 mutations involved in malignant arrhythmias 153
Implantable Cardioverter-Defibrillator Therapy in Athletes 153
Deep characterization of females with heterozygous Duchenne muscular dystrophy mutations 153
Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft 152
TAIL1: an isthmin-like gene, containing type 1 thrombospondin-repeat and AMOP domain, mapped to ARVD1 critical region. 151
Filamin C variant-associated Cardiomyopathy: A Pooled Analysis of Individual Patient Data to Evaluate the Clinical Profile and Risk of Sudden Cardiac Death 151
Noninvasive cardiac screening in young athletes with ventricular arrhythmias. 150
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. 148
Arrhythmogenic right ventricular cardiomyopathy is a life-threatening disease at high risk for cardiac arrest during effort. Minor forms are as dangerous as major forms? 148
Arrhythmogenic Right Ventricular Cardiomyopathy 148
Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities. 148
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report 147
Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. 146
Management of arrhythmogenic right ventricular cardiomyopathy 146
Late-onset arrhythmogenic right ventricular cardiomyopathy 146
Diagnosis of arrhythmogenic cardiomyopathy: 20 years of progress and innovation 145
The electrocardiographic "triangular QRS-ST-T waveform" pattern in patients with ST-segment elevation myocardial infarction: Incidence, pathophysiology and clinical implications 144
Anchoring Vignettes in EQ-5D-5L Questionnaire: Validation of a New Instrument 144
Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2) 143
Novel pathogenic role for galectin-3 in early disease stages of arrhythmogenic cardiomyopathy. 142
Myocardial Tissue Characterization in Arrhythmogenic Cardiomyopathy: Comparison Between Endomyocardial Biopsy and Cardiac Magnetic Resonance 142
Compound and Digenic Heterozygosity Contributes to Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (vol 55, pg 587, 2010) 141
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy 139
Nonischemic Left Ventricular Scar: Sporadic or Familial? Screen the Genes, Scan the Mutation Carriers 138
Prevalence of cardiomyopathy in Italian asymptomatic children with electrocardiographic T-wave inversion at preparticipation screening. 137
Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy 137
Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Athletes with Premature Ventricular Beats 137
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. 135
Is Internet use associated with anxiety in patients with and at risk for cardiomyopathy? 135
Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement 135
Differential diagnosis of arrhythmogenic cardiomyopathy: phenocopies versus disease variants 135
Contemporary diagnostic approach to arrhythmogenic cardiomyopathy: The three-step work-up 134
Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. 134
Pharmacotherapy and other therapeutic modalities for managing arrhythmogenic right ventricular cardiomyopathy. 134
Arrhythmogenic Cardiomyopathy—Current Treatment and Future Options 134
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic 132
Totale 17.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.073
article - articoli 76.122
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.349
Totale 161.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.946 0 0 0 0 201 231 77 208 345 419 334 131
2021/20222.327 97 259 317 131 127 188 114 239 149 60 201 445
2022/20231.705 310 204 53 184 248 201 20 141 202 27 75 40
2023/20241.156 36 151 108 96 83 121 82 64 69 56 157 133
2024/20255.146 31 279 198 204 498 192 359 448 483 342 839 1.273
2025/20269.753 1.060 1.549 2.652 3.225 1.267 0 0 0 0 0 0 0
Totale 27.354